New WHO Public Assessment Reports (WHOPARs) published
M
7th Invitation to manufacturers of medicinal products for treatment of Neglected Tropical Diseases (NTDs), to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Unit
M
Products added under:
Singl
Launch of pilot programme for international cooperation in GMP inspections of manufacturers of sterile medicinal products for human use
M
International collaboration in the inspection of manufacturers of active pharmaceutical ingredients has been beneficial over the last few years (1).
Hetero’s dolutegravir/lamivudine/tenofovir tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Lupin’s lamivudine/tenofovir 300mg/300mg tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list: